Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: xbrent who wrote (2837)	7/8/1998 7:47:00 PM
From: FatMatty	Respond to of 5402

Developing medical or RX types of stocks have a tremendous upside if the technology has a large market and they can get thru the trials before the cash runs out. (burn rate) If SGNC is all that it could be it could be $100 stock. But we all know that that is a real long shot. If you read all the recent posts and even take a conservative careful posture SGNC has a great chance at the big time. The market is there, the technology is logical, the CEO is well regarded, they have a plan and they are allied with others who have credibility and where-with-all. To try to quantify the value of the company at this point is somewhat futile. I guess you could do it in three ranges 1. great 2. good 3. less than good; then you have three numbers. I happen to think of all the various medical related firms that SGNC looks to me that it could be very successful and that is why I own it and will hold it. He knows this...he's got another agenda he's not willing to disclose.

To: xbrent who wrote (2837)	7/8/1998 8:05:00 PM
From: Gwolf	Read Replies (4) \| Respond to of 5402

ADDITIONAL KEY INFORMATION: I questioned Dr. Drees extensively on why no one else has brought a Flurocarbon product to market considering the fact that major universities and foreign governments are working on it. The real key to the product, come to find out, is the surfactants. Without the surfactants you don't have a complete product. The PHER-02 is 80% 0f the product and the surfactant is 20%, but no one else has been able to develop a surfactant to mix with the Flurocarbon to complete the product. I just felt like there was a piece of the puzzle missing here, I couldn't completely understand why no one else was working on this. Other companies can use the Flurocarbon but they have no workable surfactant to complete the product. So at least for me the picture becomes clear why no competition. Dr. Drees has been keeping this surfactant issue very close to the vest, this is his secret weapon so to speak. This also why he doesn't want to file a patent right now, if he did everyone could see how he has finally accomplished what no one else has been able to do. This all makes more sense now. The major drug companies don't know that he has found a surfactant, that's why their not knocking the doors down right now. When the animal trials are under way and medical reviews have been written then they will figure out that he has found a solution and come knocking. This is why the stock is undiscovered at this point in time. I hope this clears up a mystery that some of you may have been wondering about - I know I was. Gwolf